Providence Therapeutics CEO Brad Sorenson says his company’s made-in-Canada coronavirus vaccine, the first to begin clinical trials, as he has said previously, needs more support from the federal government. To read more: »»» Subscribe to CBC News to watch more…
Sabine Hazan, MD explores physician-led research currently underway seeking COVID-19 treatments that can reduce hospitalization and death. Learn more and support this work at:
Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune Response
Researchers who tested the vaccine in a combined Phase 1-2 trial — mostly meant to show safety — found either one or two doses of the vaccine generated both antibody and T-cell responses against the coronavirus. The trials were not…
As the U.S. awaits news of the COVID-19 vaccine, UC Davis Chief of Pediatric Infectious Diseases Dean Blumberg offers an update on the distribution, side effects and differences between the vaccines by Pfizer, Moderna and AstraZeneca. For the latest information…
Episode #13 Science in 5 is WHO’s conversations in science. Watch WHO experts explain science related to COVID-19. Learn what scientists look for in the different phases of a clinical trial for a vaccine. What does it mean when a…
